C
Christian Gisselbrecht
Researcher at University of Paris
Publications - 322
Citations - 29919
Christian Gisselbrecht is an academic researcher from University of Paris. The author has contributed to research in topics: Transplantation & Autologous stem-cell transplantation. The author has an hindex of 69, co-authored 317 publications receiving 27841 citations. Previous affiliations of Christian Gisselbrecht include French Institute of Health and Medical Research.
Papers
More filters
Journal ArticleDOI
CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
Bertrand Coiffier,Eric Lepage,Josette Brière,Raoul Herbrecht,Hervé Tilly,Reda Bouabdallah,Pierre Morel,Eric Van Den Neste,Gilles Salles,Philippe Gaulard,Felix Reyes,Pierre Lederlin,Christian Gisselbrecht +12 more
TL;DR: A randomized trial to compare CHOP chemotherapy plus rituximab with CHOP alone in elderly patients with diffuse large-B-cell lymphoma found the rate of complete response was significantly higher in the group that received CHOP plus r ituximabs than in thegroup that receivedCHOP alone.
Journal Article
A predictive model for aggressive non-Hodgkin's lymphoma
Margaret A. Shipp,D. P. Harrington,James R. Anderson,James Olen Armitage,Gianni Bonadonna,G. Brittinger,Fernando Cabanillas,George P. Canellos,Bertrand Coiffier,Joseph M. Connors,R. A. Cowan,D. Crowther,Steve Dahlberg,M. Engelhard,Richard I. Fisher,Christian Gisselbrecht,Sandra J. Horning,Eric Lepage,T. A. Lister,J. H. Meerwaldt,Emili Montserrat,Nis I. Nissen,M. M. Oken,Bruce A. Peterson,Carlo Tondini,W. A. Velasquez,B. Y. Yeap +26 more
TL;DR: The international index and the age-adjusted international index should be used in the design of future therapeutic trials in patients with aggressive non-Hodgkin's lymphoma and in the selection of appropriate therapeutic approaches for individual patients.
Journal ArticleDOI
Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'Adulte
P. Feugier,A. Van Hoof,Catherine Sebban,Philippe Solal-Celigny,R. Bouabdallah,Christophe Fermé,B. Christian,Eric Lepage,H. Tilly,F. Morschhauser,Philippe Gaulard,Gilles Salles,André Bosly,Christian Gisselbrecht,Felix Reyes,B. Coiffier +15 more
TL;DR: Using the combination of R-CHOP leads to significant improvement of the outcome of elderly patients with diffuse large B-cell lymphoma, with significant survival benefit maintained during a 5-year follow-up.
Journal ArticleDOI
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
Michael Crump,Sattva S. Neelapu,Umar Farooq,Eric Van Den Neste,John Kuruvilla,Jason R. Westin,Brian K. Link,Annette E. Hay,James R. Cerhan,Liting Zhu,Sami Boussetta,Lei Feng,Matthew J. Maurer,Lynn Navale,Jeff Wiezorek,William Y. Go,Christian Gisselbrecht +16 more
TL;DR: SCHOLAR-1, an international, multicohort retrospective non-Hodgkin lymphoma research study, retrospectively evaluated outcomes in patients with refractory DLBCL, the largest patient-level pooled retrospective analysis to characterize response rates and survival for a population of patients withRefractoryDLBCL.
Journal ArticleDOI
A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma
Eva Hoster,Martin Dreyling,Wolfram Klapper,Christian Gisselbrecht,Achiel Van Hoof,Hanneke C. Kluin-Nelemans,Michael Pfreundschuh,Marcel Reiser,Bernd Metzner,H. Einsele,Norma Peter,Wolfram Jung,Bernhard Wörmann,Wolf-Dieter Ludwig,Ulrich Dührsen,Hartmut Eimermacher,Hannes Wandt,Joerg Hasford,Wolfgang Hiddemann,Michael Unterhalt +19 more
TL;DR: The MIPI as discussed by the authors is the first prognostic index particularly suited for mantle cell lymphoma patients and may serve as an important tool to facilitate risk-adapted treatment decisions in patients with advanced stage MCL.